Dialybrid develops medical devices focused on vascular access solutions for hemodialysis patients. Their flagship product, the Silkothane® Arteriovenous Graft, combines silk fibroin and polyurethane to improve durability and ease of use.
Founded
2020
Total Funding
$10M+
Total Rounds
1
First Raise
Sep 22, 2026
Latest Raise
Sep 22, 2026
New funding rounds in your inbox every week · No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 9/22/2026 | |||
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week · Free